Ely Lab

Vanderbilt University Medical Center

Nashville · United States

NIH-funded
Rate this labNo reviews yet — be the first.

Research focus

NIH R01 · 2024

REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (with Baricitinib) for Long COVID Related ADRD

PROJECT SUMMARY/ABSTRACT Cognitive impairment, including Alzheimer’s Disease and Related Dementias (ADRD), and cardiopulmonary dysfunction following COVID-19, are components of the chronic syndrome known as Long COVID (LC). LC is an unprecedented public health crisis leading to cognitive, mental health, and functional disabilities for millions of people living in the United States and around the world. Large epidemiologic studies have demonstrated that the risk of ADRD increases multifold in many old and young patients following even mild SARS-CoV-2 infection. Patients with LC also frequently experience profound limitations in physical function and exercise intolerance that, when paired…

From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.

Reviews

← All labs at Vanderbilt University Medical Center